EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The PI3K-Akt-mTOR and Associated Signaling Pathways as Molecular Drivers of Immune-Mediated Inflammatory Skin Diseases: Update on Therapeutic Strategy Using Natural and Synthetic Compounds

Tithi Roy, Samuel T Boateng, Mohammad B Uddin iD, Sergette Banang-Mbeumi, Rajesh K Yadav, Chelsea R Bock, Joy T Folahan iD, Xavier Siwe-Noundou iD, Anthony L Walker iD, Judy A King, Claudia Buerger iD, Shile Huang iD und 1 weitere

Cells · 20.06.2023 · 12 (12) · 1671

DOI: 10.3390/cells12121671 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 20.06.2023. Verfasst von Tithi Roy und 12 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana at Monroe, Monroe, LA 71209, USA. Hauptthemen laut MEDLINE: Psoriasis, Dermatitis, Biological Products. Die Arbeit wurde bisher 163-mal zitiert (Crossref) und nennt 454 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, University of Louisiana at Monroe (ULM) College of Pharmacy (COP), National Institute of General Medical Sciences of the National Institutes of Health (NIGMS/NIH).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The dysregulated phosphatidylinositol-3-kinase (PI3K)-Akt-mammalian target of rapamycin (mTOR) signaling pathway has been implicated in various immune-mediated inflammatory and hyperproliferative dermatoses such as acne, atopic dermatitis, alopecia, psoriasis, wounds, and vitiligo, and is associated with poor treatment outcomes. Improved comprehension of the consequences of the dysregulated PI3K/Akt/mTOR pathway in patients with inflammatory dermatoses has resulted in the development of novel therapeutic approaches. Nonetheless, more studies are necessary to validate the regulatory role of this pathway and to create more effective preventive and treatment methods for a wide range of inflammatory skin diseases. Several studies have revealed that certain natural products and synthetic compounds can obstruct the expression/activity of PI3K/Akt/mTOR, underscoring their potential in managing common and persistent skin inflammatory disorders. This review summarizes recent advances in understanding the role of the activated PI3K/Akt/mTOR pathway and associated components in immune-mediated inflammatory dermatoses and discusses the potential of bioactive natural products, synthetic scaffolds, and biologic agents in their prevention and treatment. However, further research is necessary to validate the regulatory role of this pathway and develop more effective therapies for inflammatory skin disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PsoriasisDermatitisBiological ProductsHumansPhosphatidylinositol 3-KinaseProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesSignal TransductionTOR Serine-Threonine KinasesSirolimus

Stichwörter der Autor:innen

PI3K-Akt-mTOR signaling pathwayacneantioxidants, flavonoids and bioactive natural products/nutraceuticalsatopic dermatitisbiologics and targeted therapyphytochemicalspsoriasisskin inflammationwound healing

Substanzen

Phosphatidylinositol 3-KinaseProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesTOR Serine-Threonine KinasesSirolimusBiological Products

Autor:innen und Institutionen

  • School of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana at Monroe, Monroe, LA 71209, USA.
  • Department of Toxicology and Cancer Biology, Center for Research on Environmental Diseases, College of Medicine, University of Kentucky, Lexington, KY 40536, USA.
  • Division for Research and Innovation, POHOFI Inc., Madison, WI 53744, USA.
  • School of Nursing and Allied Health Sciences, Louisiana Delta Community College, Monroe, LA 71203, USA.
  • Department of Pharmaceutical Sciences, School of Pharmacy, Sefako Makgatho Health Sciences University, P.O. Box 218, Pretoria 0208, South Africa.
  • Department of Pathology and Translational Pathobiology, LSU Health Shreveport, 1501 Kings Highway, Shreveport, LA 71103, USA.

ORCID-Profile: Mohammad B Uddin, Joy T Folahan, Xavier Siwe-Noundou, Anthony L Walker, Claudia Buerger, Shile Huang, Jean Christopher Chamcheu

Förderung

  • NIGMS NIH HHS
  • University of Louisiana at Monroe (ULM) College of Pharmacy (COP)
  • National Institute of General Medical Sciences of the National Institutes of Health (NIGMS/NIH)
  • Louisiana Board of Regents Support Fund

Zitieren

APA

Roy, T., Boateng, S. T., Uddin, M. B., Banang-Mbeumi, S., Yadav, R. K., Bock, C. R., Folahan, J. T., Siwe-Noundou, X., Walker, A. L., King, J. A., Buerger, C., Huang, S., & Chamcheu, J. C. (2023). The PI3K-Akt-mTOR and Associated Signaling Pathways as Molecular Drivers of Immune-Mediated Inflammatory Skin Diseases: Update on Therapeutic Strategy Using Natural and Synthetic Compounds. Cells, 12(12), 1671. https://doi.org/10.3390/cells12121671

Vancouver

Roy T, Boateng ST, Uddin MB, Banang-Mbeumi S, Yadav RK, Bock CR, et al. The PI3K-Akt-mTOR and Associated Signaling Pathways as Molecular Drivers of Immune-Mediated Inflammatory Skin Diseases: Update on Therapeutic Strategy Using Natural and Synthetic Compounds. Cells. 2023;12(12):1671. doi:10.3390/cells12121671

BibTeX
@article{Roy2023,
  author = {Roy, Tithi and Boateng, Samuel T and Uddin, Mohammad B and Banang-Mbeumi, Sergette and Yadav, Rajesh K and Bock, Chelsea R and Folahan, Joy T and Siwe-Noundou, Xavier and Walker, Anthony L and King, Judy A and Buerger, Claudia and Huang, Shile and Chamcheu, Jean Christopher},
  title = {The PI3K-Akt-mTOR and Associated Signaling Pathways as Molecular Drivers of Immune-Mediated Inflammatory Skin Diseases: Update on Therapeutic Strategy Using Natural and Synthetic Compounds},
  journal = {Cells},
  year = {2023},
  volume = {12},
  number = {12},
  pages = {1671},
  doi = {10.3390/cells12121671}
}
Kostenlos starten →